Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459549086df37b5bed0003502de7e7aa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 |
filingDate |
2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff5429af211fcd0c14dc545b11a430bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_932f87969b854dfe23d178461898185e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_710256ba1d4dd187fb3448fcf0bd5e8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3619cb6afc169602217765776e3c9bd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365553a15948a4325817adef149de728 |
publicationDate |
2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017118928-A1 |
titleOfInvention |
Process for the separation of diastereomers of tenofovir alafenamide |
abstract |
The invention describes a process and diastereomeric salts useful for the optical resolution of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy] propyl] adenine and intermediates thereof. The process comprises placing into solution a chiral resolving agent, either L/D-Proline or L/D-Phenylalanine, precipitating the resulting diastereomeric salt between the chiral resolving agent and the target enantiomer and separating the enantiomer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111189947-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110283208-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111189947-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114804989-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110283208-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107522743-A |
priorityDate |
2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |